Terumo Corp. (OTCMKTS:TRUMY) Short Interest Update

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a large decline in short interest in September. As of September 30th, there was short interest totaling 28,900 shares, a decline of 79.4% from the September 15th total of 140,300 shares. Based on an average daily volume of 234,000 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 234,000 shares, the short-interest ratio is currently 0.1 days.

Terumo Stock Performance

Shares of TRUMY opened at $16.61 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.53 and a current ratio of 2.64. The stock has a 50 day moving average price of $17.39 and a two-hundred day moving average price of $17.90. The firm has a market capitalization of $24.59 billion, a P/E ratio of 29.14 and a beta of 0.79. Terumo has a 52 week low of $15.64 and a 52 week high of $21.22.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.03. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.80 billion. Terumo had a return on equity of 9.19% and a net margin of 12.09%.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.